Brief: Patent Issued For Calliditas Setanaxib In USA
18/06/2024 12:49
June 18 (Reuters) - Calliditas Therapeutics AB CALTX.ST :
* CALLIDITAS PROVIDES SETANAXIB PATENT UPDATE
* UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO) HAS ISSUED A PATENT FOR APPLICATION NO.
16/760,910
Source text for Eikon: ID:nWkr9yYwjD
Further company coverage: CALTX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Calliditas Therapeutics AB
See all newsBrief: Calliditas To Be Delisted From Nasdaq Stockholm
Brief: Calliditas Therapeutics Takes Certain Corporate Actions Following Announcement By Asahi Kasei
Brief: Asahi Kasei Corp: Notice Regarding Results Of Tender Offer For Shares Of Calliditas Therapeutics AB And Transfer Of Subsidiary
Calliditas Therapeutics AB reports results for the quarter ended in January - Earnings Summary
Brief: Calliditas Q2 Sales Beat Expectations